Alex Nikitine

Walder Wyss Ltd. - SWITZERLAND


Alex Nikitine's competencies

Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Corporate M&ASWITZERLAND29176073611
Equity Capital MarketsSWITZERLAND29250100001
Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Showing 1 to 2 of 2 entries

Client Reviews

The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessment


Communication Skills

0255075100Below expectationMeet expectationExceed expectation0

Technical skills

0255075100Below expectationMeet expectationExceed expectation0

Efficiency

0255075100Below expectationMeet expectationExceed expectation0


Effectiveness

0255075100Below expectationMeet expectationExceed expectation0



Perceived Added Value

0255075100

Ranking 2022: Alex Nikitine - Walder Wyss Ltd.

Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Corporate M&A167583010
Equity Capital Markets25551252
Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Showing 1 to 2 of 2 entries

Ranking 2021: Alex Nikitine - Walder Wyss Ltd.

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Corporate M&A1253655
Equity Capital Markets7002502
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2020: Alex Nikitine - Walder Wyss Ltd.

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Corporate M&A1030015797
Equity Capital Markets5252173
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Significant Clients

The chart shows a balanced list of the Alex  Nikitine's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve Mounths
Yasai AGWISAG Service Holdings LuxembourgSARLSulzer & Schmid Laboratories AGSkyCell AGKlar PartnersENANTIOSembotech AGCorFlow Therapeutics Ltd.Bregal UnternehmerkapitalANYbotics AGALENTIS Therapeutics02.5K5KRevenue (ML. Euro)

Team

The chart shows a balanced list of counselor working with Alex  Nikitine - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Janine CortiMaurus WinzapStefan WalderThomas MüllerMichelle SollbergerMichael KisslingAndré KuhnViktoriya ChernayaSimone WetzsteinNadja LeuthardtMarina SrienzManu FerroLetizia Schlegel Katja RauberIsabell SchellhasHugh ReevesFabian AkeretErik LanzDominik AerniDario GalliAndrea HaefeliAlice VorburgerValentinWiesnerValentinFreiermuthTimonNydeggerStefanKnoblochSarah VettigerRogerAmmannReto VonzunRemo DiMarcoNico BernhardMilos KaricMichaelLysakowskiMichael KündigMarius DenothLukas WyssKentoReutimannKatjaSchott-MorgenrothKarina TschonJulia Lehner JohannesStammJérôme HemanJenny von ArxIliana DjagovaFlorian ItenFabienneLimacherFabian LooserChristianSchmidCeline WeberCarmenSpichigerBertrand DonzéBenjaminSuterBenjaminSommerhalderBenjamin ReisAnnemarieLaggerAngelinaPellegriniAminaChammahAlexanderGutmans0277.5555Agg. deal value (ML. Euro)

Co-Counsel

The Chart shows a balanced list of Alex  Nikitine's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Linklaters012.525Agg. deal value (ML. Euro)

Counterparts

The Chart shows a balanced list of Alex  Nikitine's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Niederer Kraft Frey LtdWenger VieliVISCHER AGBär & KarrerHonigman LLPBGPartnerLenz & StaehelinKellerhals Carrard092.5185Agg. deal value (ML. Euro)

Peer Reviews

The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessment


0%20%40%60%80%100%Communication SkillsTechnical skillsEfficiencyEffectivenessPerceived Added Value

Recent experiences

WISAG Group's Acquisition Of Stampfli AG5/27/2025
Embotech AG's CHF23.5 Million Series B Investment Round12/19/2024
ANYbotics AG's $60 Million Financing Round12/19/2024
Embotech AG's CHF23.5 Million Series B Investment Round12/19/2024
ANYbotics AG's $60 Million Financing Round12/19/2024
Alentis Therapeutics' $181.4 Million Series D Financing Round11/20/2024
CorFlow Therapeutics AG's €44 Million Series B Financing Round9/19/2024
RES' Acquisition Of Sulzer & Schmid Laboratories AG9/6/2024
Bregal Unternehmerkapital's Acquisition Of Majority Stake In BSI Software From Capvis7/12/2024